Cellmid 2017 Annual Report

NOTES TO THE

FINANCIAL STATEMENTS

CONTINUED

*Options were either exercised or lapsed during the ﬁnancial year ended 30 June 2017.

The holders of ordinary shares are entitled to participate in dividends and the proceeds on winding up of the Company. On a

show of hands at meetings of the Company, each holder of ordinary shares has one vote in person or by proxy, and upon a poll

each share is entitled to one vote.

The Company does not have a limited amount of authorised capital and the fully paid ordinary shares have no par value.

18. ISSUED CAPITAL

2017 2016 2017 2016

Shares Shares $ $

Ordinary shares – fully paid 1,072,456,303 928,500,508 36,715,031 31,794,565

Unissued ordinary shares under option* 34,440,000 330,954,732 - 632,261

36,715,031 32,426,826

Consolidated

Issue Price 2017 2016 2017 2016

$ No. No. $ $

(a) Ordinary shares

At the beginning of the year 928,500,508 95,167,175 31,794,565 28,069,050

Shares issued – May 2017 0.027 2,074,074 - 56,000 -

Shares issued – March 2017 0.0306 1,000,000 - 30,600 -

Shares issued – March 2017 0.02 700,000 - 14,000 -

Shares issued – March 2017 0.034 250,000 - 8,500 -

Shares issued – March 2017 0.023 4,565,218 - 105,000 -

Shares issued – November 2016 0.03 35,483,334 - 1,064,500 -

Shares issued – November 2016 0.03 63,516,666 - 1,905,500 -

Shares issued – October 2016 0.034 32,394,541 - 1,101,401 -

Shares issued – October 2016 0.03 3,971,962 - 119,159 -

Shares issue costs, net of tax - - - (116,455) -

Listed options exercised/lapsed* - - 632,261 -

Shares issued – September 2015 0.03 - 23,333,333 - 700,000

Shares issued – August 2015 0.03 - 110,000,000 - 3,300,000

Shares issue costs, net of tax - - - (274,485)

At the end of the year 1,072,456,303 928,500,508 36,715,031 31,794,565